Intermittent Fasting With Glp 1 For Reduce Oxidative Stress

Intermittent Fasting with GLP-1 for Reduced Oxidative Stress

Oxidative stress is a major contributor to the development and progression of various diseases, including obesity, diabetes, and cardiovascular disease. Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) have been shown to provide substantial benefits in weight reduction, glycemic control, and cardiovascular protection. Intermittent fasting (IF) has also been proposed to elicit beneficial effects similar to calorie restriction, including reduced oxidative stress.

GLP-1 and Oxidative Stress

GLP-1, a gastrointestinal peptide and central mediator of glucose metabolism, is secreted by L cells in the intestine in response to food intake. Studies have shown that GLP-1 can reduce inflammation and oxidative stress, key players in aging and disease. They have been linked to reduced risks of heart disease, stroke, and even certain cancers, prompting investigations into their potential for treating Alzheimer's, arthritis, and more.

Intermittent Fasting and Reduced Oxidative Stress

Intermittent fasting has been shown to reduce oxidative damage and inflammation in the body, leading to benefits related to aging and the development of numerous diseases. It has been proposed that IF may promote antioxidants, including glutathione, superoxide dismutase, and Nrf2, which decrease the generation of reactive oxygen species (ROS). Research has also demonstrated that IF can reduce oxidative stress markers and less brain damage in animal models of cerebral hypoperfusion and stroke.